Skip to main content

Table 1 Patient and Tumor Characteristics

From: Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy

Number of patients

160

Age

6.1 (±9.6)

Gender (% male)

72.5 % (116/160)

Disease site

 Tonsil

84

 DOT

70

 Soft palate

3

 Oropharynx (other)

3

Tumor

 T1

54

 T2

42

 T3

35

 T4

29

Nodal Status

 N0

12

 NI

29

 N2 (N2a, N2b, N2c)

108 (67, 14, 27)

 N3

11

TNM Stage

 Stage III

38

 StagelV

122

 Salivary gland transfer

38